Poor Adherence Predictors and Factors Associated with Antiretroviral Treatment Failure among HIV Seropositive Patients in Western Nigeria
Journal Title: International STD Research & Reviews - Year 2017, Vol 6, Issue 3
Abstract
Background: The efficiency and success of antiretroviral therapy (ART) depends on a good level of patient’s adherence to a life-long regimen of antiretroviral (ARV) which is beneficial in reducing the risk of emergence of HIV resistant strains. This adherence is however influenced by several factors related mainly to patient and medication. This study is therefore carried out to determine the adherence rate of adult patients infected with HIV and identify the factors associated with antiretroviral therapy (ART) interruption or poor adherence. Methods: This cross sectional study was carried out in Ondo & Ekiti States, South Western Nigeria. The target population was adult patients living with HIV and already initiated on ART. Data was collected by trained volunteers and supervised by appointed supervisors, by a face-to-face interview. All data were statistically analysed, using statistical package for the social sciences (SPSS) and statistical test of significance was performed with Chi-Square test. Results: A total of 412 consenting respondents participated in the study with a mean age ± SD is 37.93 ± 9.30 years. 116 (40.8%) of them are males while 244 (59.2%) are females. ART adherence level was 79.6%. The main factor associated with ART adherence was educational status (χ² = 16.18, df = 3, P = 0.001). Drug reminder strategy have lower association with missing ART drug (OR: 0.51, 95% CI: 0.28 – 0.92) while patients experiencing ART drug side effect have higher association with missing ART drug (OR: 1.82, 95% CI: 1.01 – 3.28). Conclusion: ART adherence is sub-optimal, with barriers largely patient-dependent thus it is imperative to intensify medication adherence counselling in an holistic behavioural educational improvement strategy aimed at improving the ability to fit therapy into own lifestyle, avoid drug exhaustion, achieve optimal adherence and remarkable patient outcome.
Authors and Affiliations
Saheed Opeyemi Usman, Gbemiga Peter Olubayo, Oluwole Tosin Oluwaniyi, Abayomi Joseph Afe, Ganiyu Babatunde Agboola, Olufunmi Abodunde, Timothy Akinmurele, Olatoun Adeola, Maduakolam Onyema
Keywords
Related Articles
- EP ID EP305512
- DOI 10.9734/ISRR/2017/38469
- Views 108
- Downloads 0
Vulnerability and Gonorrhea: A Qualitative Study of Black Women in South Africa
Background: Gonorrhea is becoming a health concern globally due to its susceptibility to resistance of antibiotics, and this is a concern particularly for Black women in South Africa. Vulnerability among Black women lead...
Youths' Reproductive Health and Risk Perception to Sexually Transmitted Infections in Communities in Bayelsa State, Nigeria: A Qualitative Study
Aims: Young people especially in sub-Saharan Africa are at great risk of contracting HIV. Studies have shown that young people aged 15–24 account for an estimated 45% of new HIV infections worldwide while less than half...
90-90-90 Ambitious Targets: Achieving the Last 90 of the UNAIDS Targets in Western Nigeria
Background: In resource-limited settings, where genotypic drug resistance testing is rarely performed and poor adherence is regarded as the most common reason for treatment failure, programmatic approaches to handling tr...
Factors Determining the Use of Condoms at the Onset of Pre-marital Sexual Relationships among Never Married Youths in Zambia
An emerging public health concern is the high risk of sexual behaviour among youths with increasing number of sexually active youths in developing countries engaging in premarital sex, more especially in sub-Saharan Afri...
Barriers and Facilitators of Adherence in User-Dependent HIV Prevention Trials, a Systematic Review
Background: Suboptimal adherence to investigational products has been associated with ineffectual outcomes in clinical trials. This review provides a summary of factors that influenced adherence in HIV prevention trials....